

					

						November 27, 2017 - By Kurt Siggers
Among 15 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 3 Sell and 7 Hold. Therefore 33% are positive. Novartis Ag had 33 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was upgraded by Barclays Capital on Friday, June 23 to “Hold”. The firm earned “Hold” rating on Friday, October 13 by Cowen & Co. The firm has “Hold” rating given on Thursday, June 22 by Leerink Swann. The rating was maintained by J P Morgan Chase Co on Friday, June 16 with “Neutral”. The firm has “Neutral” rating by JP Morgan given on Friday, March 24. The company was downgraded on Wednesday, July 5 by Credit Suisse. Citigroup downgraded the stock to “Neutral” rating in Tuesday, March 29 report. The firm has “Buy” rating given on Tuesday, September 20 by Chardan Capital Markets. The stock has “Buy” rating by Societe Generale on Wednesday, March 8. The firm has “Hold” rating by Cowen & Co given on Wednesday, August 9. See Novartis AG (ADR) (NYSE:NVS) latest ratings:25/10/2017 Broker: Barclays Capital Rating: Sell Downgrade23/10/2017 Broker: Leerink Swann Rating: Market Perform Old Target: $89 New Target: $91 Maintain13/10/2017 Broker: Cowen & Co Rating: Hold New Target: $90.0 Maintain11/09/2017 Broker: Cowen & Co Rating: Hold New Target: $90.0 Maintain09/08/2017 Broker: Cowen & Co Rating: Hold New Target: $90.0000 Maintain26/07/2017 Broker: Morgan Stanley Old Rating: Underweight New Rating: Overweight Upgrade18/07/2017 Broker: Cowen & Co Rating: Hold Maintain10/07/2017 Broker: Cowen & Co Rating: Hold New Target: $77.0000 Maintain23/06/2017 Broker: Barclays Capital Rating: Hold Upgrade22/06/2017 Broker: Leerink Swann Rating: Hold MaintainThe stock of Bruker Corporation (NASDAQ:BRKR) hit a new 52-week high and has $36.26 target or 3.00% above today’s $35.20 share price. The 7 months bullish chart indicates low risk for the $5.48B company. The 1-year high was reported on Nov, 27 by Barchart.com. If the $36.26 price target is reached, the company will be worth $164.40 million more. About 13,579 shares traded. Bruker Corporation (NASDAQ:BRKR) has risen 0.54% since November 27, 2016 and is uptrending. It has underperformed by 16.16% the S&P500.Novartis AG is a holding company, which provides healthcare solutions. The company has market cap of $222.28 billion. The Firm is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. It has a 30.22 P/E ratio. The Company’s divisions include Innovative Medicines, Sandoz, Alcon and Corporate activities. About 50,735 shares traded. Novartis AG (ADR) (NYSE:NVS) has risen 7.67% since November 27, 2016 and is uptrending. It has underperformed by 9.03% the S&P500.Analysts await Bruker Corporation (NASDAQ:BRKR) to report earnings on February, 12. They expect $0.49 earnings per share, up 6.52% or $0.03 from last year’s $0.46 per share. BRKR’s profit will be $76.28 million for 17.96 P/E if the $0.49 EPS becomes a reality. After $0.29 actual earnings per share reported by Bruker Corporation for the previous quarter, Wall Street now forecasts 68.97% EPS growth. Since June 8, 2017, it had 0 buys, and 2 selling transactions for $2.59 million activity. VAN INGEN CHRIS sold 19,900 shares worth $557,889. $2.04 million worth of Bruker Corporation (NASDAQ:BRKR) was sold by Munch Mark on Thursday, June 8.Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. The company has market cap of $5.48 billion. The Company’s divisions include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. It has a 37.33 P/E ratio. The Bruker BioSpin Group segment designs, makes and distributes enabling life science tools.Among 16 analysts covering Bruker (NASDAQ:BRKR), 3 have Buy rating, 2 Sell and 11 Hold. Therefore 19% are positive. Bruker has $38.0 highest and $15 lowest target. $27.39’s average target is -22.19% below currents $35.2 stock price. Bruker had 40 analyst reports since August 20, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained it with “Hold” rating and $23.0 target in Thursday, November 5 report. Cowen & Co maintained Bruker Corporation (NASDAQ:BRKR) rating on Monday, August 14. Cowen & Co has “Hold” rating and $2900 target. The rating was initiated by Deutsche Bank with “Hold” on Thursday, January 7. The stock of Bruker Corporation (NASDAQ:BRKR) has “Underperform” rating given on Thursday, July 13 by Wells Fargo. Cantor Fitzgerald upgraded the shares of BRKR in report on Monday, January 25 to “Buy” rating. The firm has “Buy” rating given on Friday, June 9 by Jefferies. The stock of Bruker Corporation (NASDAQ:BRKR) earned “Sell” rating by Goldman Sachs on Tuesday, September 26. As per Thursday, November 10, the company rating was reinitiated by Leerink Swann. The company was downgraded on Friday, November 3 by JP Morgan. Jefferies maintained the stock with “Buy” rating in Sunday, September 10 report.Investors sentiment increased to 1.14 in 2017 Q2. Its up 0.29, from 0.85 in 2017Q1. It improved, as 22 investors sold Bruker Corporation shares while 58 reduced holdings. 31 funds opened positions while 60 raised stakes. 100.40 million shares or 2.18% less from 102.64 million shares in 2017Q1 were reported. Smithfield Tru Co invested in 4,770 shares or 0.02% of the stock. Panagora Asset Mngmt Inc owns 597,867 shares. Qs Investors Ltd Liability Co has 5,167 shares. Cubist Systematic Strategies Ltd Com holds 16,478 shares or 0.03% of its portfolio. Royal National Bank & Trust Of Canada has 0% invested in Bruker Corporation (NASDAQ:BRKR). Fayez Sarofim holds 0% of its portfolio in Bruker Corporation (NASDAQ:BRKR) for 7,060 shares. Prudential owns 144,342 shares. Envestnet Asset Management reported 0% in Bruker Corporation (NASDAQ:BRKR). Wellington Mgmt Group Limited Liability Partnership has invested 0% in Bruker Corporation (NASDAQ:BRKR). Architects holds 0% or 75 shares in its portfolio. 1.07M are owned by London Co Of Virginia. Ny State Common Retirement Fund holds 0.02% or 542,166 shares. Dimensional Fund Advsr Limited Partnership has invested 0.01% in Bruker Corporation (NASDAQ:BRKR). Advisory Net Limited Liability Corp accumulated 0.03% or 6,847 shares. United Kingdom-based Hsbc Public Limited Co has invested 0% in Bruker Corporation (NASDAQ:BRKR).Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.


		var data = "63557954";
		document.write('<ins class="adsbygoogle" style="background-color:transparent; display:inline-block;width:300px;height:600px;" data-ad-client="ca-pub-16900'+data+'675" data-ad-slot="8925061741"></ins>')
	
(adsbygoogle = window.adsbygoogle || []).push({});
(adsbygoogle = window.adsbygoogle || []).push({});